PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Polyporus umbellatus polysaccharide (PUPS) capsules and injections are SFDA-approved drugs used alone or in combination for treating Hepatitis B [PMID: 31030753]
Polysaccharides from P. umbellatus sclerotia (PPUS) improved renal function and ameliorated renal collagen deposition and fibrosis [PMID: 30832835]
Aqueous extract of sclerotia and polyporus polysaccharide were effective in inhibiting bladder carcinogenesis in female Fischer-344 rats [PMID: 21213404]
P. umbellatus inhibited tumor cell proliferation and volume in nude mice by down-regulating AKT [PMID: 27447121]
PUP reduced bone loss, cartilage degradation, and joint edema in CIA mouse models [PMID: 40527375]
Evidence summary
PubMed sources
- 1.PMID: 23811047 (2013) — Traditional uses, phytochemistry, pharmacology, pharmacokinetics and quality control of Polyporus umbellatus (Pers.) Fries: a review. · Journal of ethnopharmacology
- 2.PMID: 31030753 (2019) — The efficacy of Polyporus Umbellatus polysaccharide in treating hepatitis B in China. · Progress in molecular biology and translational science
- 3.PMID: 40527375 (2025) — Polyporus Umbellatus polysaccharide ameliorates rheumatoid arthritis via inhibiting inflammation and regulating gut microbiota. · International journal of biological macromolecules
- 4.PMID: 32749102 (2020) — Do the Main Components of the Sclerotia of Umbrella Polypore Mushroom, Polyporus umbellatus (Agaricomycetes), Correlate with Armillaria Associates? · International journal of medicinal mushrooms
- 5.PMID: 35667259